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Objective: To investigate the molecular epidemiology o f  fluoroquinolone-resistant (FQ-R) and fluoroquinolone- 
susceptible (FQ-S) bacteremic Escherichia coli isolates from neutropenic patients by  pulsed-field gel electrophoresis 
(PFGE) and random amplified polymorphic DNA (RAPD) analysis. 
Methods: Nineteen FQ-R and 27 FQ-S isolates of E. coli, obtained from patients on a hematologic ward over a 7-year 
period, were genotyped by PFGE and RAPD using two different random primers (1247 and 1283). 
Results: PFGE analysis was able to type all FQ-S isolates and most (17/19,89%) FQ-R isolates of E. coli. All isolates were 
genotypically unrelated, with the exception of two indistinguishable FQ-R isolates from different patients in  the same 
period. RAPD analysis typed all isolates, including those FQ-R isolates untypable by PFGE, but was unable to  distinguish 
between some isolates that were different by PFGE. Using primer 1247, RAPD analysis identified six pairs and one triad, 
while primer 1283 identified seven pairs and one triad of indistinguishable isolates. 
Conclusions: No spread of epidemic FQ-R or FQ-S E. coliisolates was documented among neutropenic patients. RAPD 
analysis is a powerful genotyping method, but appeared to  be less reproducible and discriminatory than PFGE for 
investigating E. coli isolates. 
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INTRODUCTION 
Fluoroquinolones are potent antimicrobial agents used 
in the treatment and prophylaxis of community- 
acquired and nosocomial infections [l]. When the new 
fluorinated quinolones were introduced more than 10 
years ago, optimism concerning their usefulness in the 
prophylaxis of febrile neutropenia was justified by their 
broad antibacterial spectrum, high intraluminal concen- 
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tration, systemic bactericidal activity, good tolerability, 
and apparent lack of potential for development 
of resistance [l]. All these characteristics contribute 
to their widespread use for antibacterial chemo- 
prophylaxis in neutropenic patients [2 ,3] .  Although the 
risk of development of resistance was considered to be 
extremely low [4], after their introduction to clinical 
practice an increasing emergence of quinolone-resistant 
bacteria was documented [5-71, particularly in 
Staphylococcrrs aureus and Pseudo~nonas aerugitzosa [8,9]. 
The emergence of high-level fluoroquinolone-resistant 
(FQ-R) strains (MIC >128 mg/L) has also been 
reported for various members of the Entero- 
bacteriaceae f a d y ,  including Esrhericltia coli [ 10-121. A 
clear association was observed between increased use of 
quinolones and emergence of fluoroquinolone resist- 
ance. Neutropenic patients with cancer who receive 
prophylaxis with fluoroquinolones may be at risk of 
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Table 1 Distribution from 1990 to 1996 of E. coli bacteremic isolates from a hematologic ward in Rome 
~ ~ ~~~~ 
No. of No. (%) of No. of No. (“A) of No. of 
E .  coli E. coli FQ-R” E. coli FQ-R” E.  coli FQ-Sb E. coli FQ-Sb 
Year bacteremias isolates isolates studied isolates isolates studied 
1990 21 2 (10) 2 19 (90) 16 
1991 10 2 (20) 1 8 (80) 5 
1992 16 6 (37.5) 2 10 (62.5) 1 
1993 33 16 (48) 17 (52) - 
1994 43 33 (77) 3 10 (23) 1 
1995 27 21 (78) 5 6 (22) 3 
1996 9 7 (78) 6 2 (22) 1 
“FQ-R: fluoroquinolone-resistant strains; MIC24 mg/L. 
bFQ-S: fluoroquinolone-susceptible strains; MICS 1 mg/L. 
developing E. coli bacteremia due to FQ-R strains [13], 
and resistant E. coli isolates from the hematologic ward 
in Rome, Italy appeared after the introduction of 
fluoroquinolone prophylaxis for neutropenia, increas- 
ing from 5% to 78% between 1990 and 1996. The 
increasing rate of breakthrough bacteremias with 
resistant E. coli seems to be due to the independent 
emergence of several new clones [14]. However, 
nosocomial transmission may contribute to these 
resistant strains becoming a cause of concern [15]. 
Phenotypic characterization of E. coli isolates has 
proved to be inadequate for identi~ing strain diversity 
or similarity, which thus requires genotypic analysis. 
Various different typing methods have been used to 
study the genotypes of bacteria involved in nosocomial 
infections. Pulsed-field gel electrophoresis (PFGE) is 
the method of reference, although it is costly, time- 
consuming, and requires expensive instrumentation 
and trained personnel [16]. PCR typing methods, e.g. 
random amplified polymorphic DNA (RAPD) analysis 
[17-191, are rapid and less expensive, but are not 
standardized because there is no consensus regarding 
the conditions, instruments, enzymes and primers to be 
used [20,21]. 
The aim of this study was to investigate the 
molecular epidemiology of FQ-R and fluoroquinolone- 
susceptible (FQ-S) isolates of E. coli causing bacteremia 
in neutropenic patients with two different typing 
methods, i.e. PFGE versus RAPD analysis. 
MATERIALS AND METHODS 
E. Cali bacteremic isolates 
FQ-R and FQ-S isolates of E.  coli responsible for 
clinically significant bacteremia in patients admitted to 
the hematologic ward of the University ‘La Sapienza’ 
in Rome, Italy from 1990 to 1996 and available as stock 
cultures (-70°C) were analyzed. Not all isolates from 
this period were available for analysis, but 19 FQ-R and 
27 FQ-S E. coli isolates were included in the study 
(Table 1). Blood cultures were initially performed by 
the BacTec method (Becton Dickinson, Sparks, MD, 
USA) and the isolates were identified as E. coli by a 
standard in-house method [22], including biochemical 
reactions determined by the API 20E system 
(BioMkrieux, Marcy L‘Etoile, France). 
The classification of E. coli blood isolates as FQ-S 
or FQ-R isolates was determined from the MIC 
of ciprofloxacin. A standard broth microdilution 
procedure with cation-adjusted Muller-Hinton broth 
(Oxoid, Basingstoke, UK) and a final inoculum of 
5x10’ CFU/L was used, with breakpoint concen- 
trations for susceptible ( 5 1  mg/L) and resistant 
( 1 4  mg/L) strains, according to the NCCLS perfor- 
mance and interpretive guidelines [23]. All reagents, 
except where specified, were purchased from Sigma 
(St Louis, MO, USA). 
PFGE 
E. coli isolates were grown overnight in 10mL of 
brain-heart infusion broth (BHI, Oxoid). After 
incubation, bacteria were harvested, washed twice in 
PIV buffer (1 M NaC1, 10 mM Tris-HC1, pH 7.6) and 
resuspended in PIV buffer to achieve an extinction 
coefficient of 0.9 at a wavelength of 550 nm. A 0.5-mL 
aliquot of this bacterial suspension was quickly mixed 
with 0.5mL of 1.5% (w/v) Incert agarose (FMC, 
Rockland, ME, USA). After agarose plug casting, 
samples were transferred to 5 mL of lysing solution 
(6 mM Tris-HC1 (PH 7.6), 1 M NaCl, 100 mM EDTA 
(pH 7.5), 0.2% deoxycholate, 0.5% sodium lauroyl 
sarcosine, 20 pg/mL of RNase, 1 mg/mL lysozyme) 
and incubated overnight for 24 h. The plugs were 
transferred to ESP solution (0.5 M EDTA (PH 9), 1% 
sodium lauroyl sarcosine, 100 pg/mL of proteinase K) 
and incubated for 48 h at 5OOC.  The plugs were washed 
twice with phenylmethylsulfonyl fluoride (PMSF) 
1 mM in TE buffer (10 mM Tris-HC1, 1 mM EDTA 
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(pH 7.5)) and three times with TE buffer. NbaI (New 
England BioLabs, Beverly, MA, USA) was used for 
cleavage. Plugs were equilibrated in 250 pL of 
restriction buffer plus spermidine (1 mM), and cleavage 
was performed overnight with 40 U of enzyme. 
Electrophoresis was performed in 1% (w/v) 
FastLane agarose (FMC), at  14°C in TBE buffer 
(89 mM Tris-borate, 2 mM EDTA (pH 8.5)). PFGE 
was performed in a Chef Mapper apparatus (Bio-Rad 
Laboratories, Hercules, CA, USA). The pulse time was 
ramped from 1 to 50 s over 24 h at 200 V. Lambda 
concatemers (Bio-Rad) were used as DNA size 
markers. Gels were then stained with ethidium 
bromide and acquired digitally (Gel Doc 1000, Bio- 
Rad). Restriction fragment patterns were analyzed 
with MA Fingerprinting software (Bio-Rad) . Simi- 
larity coefficient (Sm)  values were calculated directly 
by the software. Since band position alone was used, 
Sm values ranged &om 0 to 1 .O, where 0 indicates that 
the fingerprints had no bands in common and 1.0 
indicates that the fingerprints were identical. The 
unwarping of gels requires subjective input from the 
investigator, so pairs of strains with Sm values 20.9 
were regarded as highly similar and not distinguishable 
by PFGE. The cut-off value of 0.9 was based on 
previous experience of using the software to compare 
profiles of the same run on different gels with various 
degrees of gel warping [24,25]. 
RAPD analysis 
RAPD fingerprinting was performed as described by 
Berg et a1 [26]. Overnight broth cultures of E. coli were 
centrifuged, and the pellet was diluted 10-fold in 
distilled water, boiled, and used as DNA template. As 
a negative control, a strain of Acinetobacter baurnarzrzii 
(LF6), untypable with primer 1247, was used. 
For PCR,  the 10-nucleotide primers 1247 
(AAGAGCCCGT) and 1283 (GCGATCCCCA), used 
previously to type FQ-R E. coli isolates [14], were used. 
P C R  was carried out in 50-pL volumes containing 
2.5 U of Tdq polymerase (Finnzyme, Riihitontuntie, 
Finland), P C R  buffer (10 mM Tris-HC1, p H  7.5), 
50 m M  KCI, 3 mM MgC12, 1.25 mM (each) deoxy- 
nucleoside triphosphates (Promega, Madison, WI, 
USA), 1OmM primer, and 5 pL of E. coli DNA 
template. The P C R  consisted of 40 cycles comprising 
94OC for 1 min, 36OC for 1 min, and 72OC for 2 min. 
Amplicons were visualized, after electrophoresis in 
1.5% (w/v) agarose gels, under UV light. Analysis was 
as described for PFGE. 
Discriminatory power 
To compare the efficacy of the two typing methods 
(PFGE versus RAPD analysis), the discriminatory 
index of Hunter and Gaston was employed [27].This 
index represents the probability that two unrelated 
strains will be characterized as being of different types 
by a given typing system. Therefore, a discriminatory 
index value close to 1 indicates the most powerful 
method for typing a given species of bacteria. 
Table 2 Ciprofloxacin MICs for E. coli isolates included in 
the study 
Ciprofloxacin 
Isolate Patient Isolation MIC 
identification identification date ( M L )  
L59 1 
Lh 1 2 
L62 3 
L64 4 
L6 6 5 
L67 6 
L68 7 
L69 8 
L70 9 
L7 1 10 
L72 11 
L71 12 
L75 13 
L76 14 
L78 15 
L79 16 
L80 17 
LS2 18 
L83 19 
L87 20 
L90 21 
L132 22 
L177 23 
L194 24 
L198 25 
L200 26 
L278 27 
L281 28 
L282 29 
L346 30 
L347 23 
L394 31 
L402 32 
L412 33 
L421 34 
L426 35 
L428 36 
L433 37 
L444 38 
L445 39 
L449 40 
L45 1 41 
L454 42 
L456 43 
L457 44 
L467 45 
12 January 1990 
23 April 1990 
25 May 1990 
4 June 1990 
23 July 1990 
I 3  August 1990 
6 February 1990 
7 September 1990 
3 October 1990 
10 October 1971 
11 October 1990 
25 October 1990 
28 October 1990 
21 November 1990 
23 December 1990 
29 December 1990 
31 December 1990 
25 February 1991 
16 March 1991 
2 September 1991 
17 Dccember 1991 
27 July 1991 
17 July 1991 
30 July 1991 
9 September 1992 
13 September 1992 
31 January 1994 
11 February 1994 
7 February 1994 
19 June 1995 
1 October 19W 
11 June 1995 
19 July 1995 
17 September 1995 
9 October 1995 
21 October 1995 
28 October 1995 
6 November 1995 
7 January 1996 
9 January 1996 
15 January 1996 
18 January 1996 
12 February 1996 
20 February 1996 
20 February 1996 
24 May 1996 
0.5 
0.5 
0.25 
0.5 
0.125 
0.125 
0.0625 
0.5 
0.125 
0.125 
0.125 
0.125 
0.125 
0.125 
0.125 
0.125 
0.115 
0.125 
2000 
0.125 
2000 
inoo 
1 000 
2u0n 
0.125 
0.125 
0.125 
2000 
1000 
2000 
1 000 
1 (lo( l
1000 
I om 
0.125 
0.125 
0.125 
1000 
1000 
2000 
1000 
2000 
2000 
1000 
0.125 
0.125 
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RESULTS 
The ciprofloxacin MICs for the E. coli isolates included 
in the study are shown in Table 2. PFGE typed 17 of 
the 19 isolates of FQ-R E. coli examined. Two isolates 
(L444 and L62) were not typable, showing only a 
diffuse DNA band of between 150 and 350 kb in size. 
Fifteen of the 17 typable isolates were unrelated. Two 
isolates (L454 and L456), obtained from different 
patients in the same period (February 1996), were 
indistinguishable (Sm’0.9). Two other isolates (L177 
and L347), obtained from the same patient during two 
episodes of bacteremia occurring 1 year apart, were 
different ( SAB = 0.25). 
All 27 FQ-S isolates were typable by PFGE and 
were unrelated. No relationship was found between 
FQ-S and FQ-R isolates. All FQ-R E. coli isolates were 
typable by RAPD analysis using the primer 1247, and 
five pairs and one triad of indistinguishable isolates 
were identified (L449-L177, L412-L457, L444-L445, 
All FQ-R strains were also typable with primer 
1283, which was able to identifj four pairs of indis- 
tinguishable isolates (L454-L456, L449-L177, L445- 
L444, L281-L428). These four pairs were identical to 
four of the five pairs identified with primer 1247. One 
of these pairs (L454-L456) was also found to be 
indistinguishable by PFGE analysis. The two isolates 
that were not typable with PFGE (L444 and L62) were 
successfully typed by RAPD analysis and were 
unrelated. 
RAPD analysis with primer 1247 identified only 
one indistinguishable pair of FQ-S isolates (L68-L6 l), 
while primer 1283 identified three pairs and one triad 
of indistinguishable isolates (L426-L433, L59-L61, 
L200-Ll98, L79-L76-L132). No pairs or triads of 
indistinguishable FQ-S isolates were common to both 
primers. 
The discriminatory index was 0.999 for PFGE, 
0.992 for RAPD with primer 1247, and 0.991 for 
RAPD with primer 1283. 
L281-L428, L454L456, L62-L98-L194). 
DISCUSSION 
Accordmg to the PFGE results, horizontal spread of a 
single clone of FQ-R E. coli in the hematologic ward 
in Rome appears to be a rare event and does not 
represent a cause of concern in terms of infection 
control. Furthermore, no genotype correlation was 
found among FQ-S isolates and between FQ-R and 
FQ-S isolates. Horizontal transmission has, however, 
been described previously for several multiresistant 
enteric bacteria [28,29]. It is noteworthy that hori- 
zontal spread of resistant clones of E .  coli was reported 
in the Cancer Center of Ulm [15]. However, reports 
suggest that resistance to quinolones in E. coli is mainly 
of multiclonal origin [14]. Oethinger et al evaluated 
FQ-R isolates of E. coli from several centers in Europe 
and the Middle East and found no correlation between 
strains provided by different hospitals, supporting the 
lack of horizontal transmission [14]. In the present 
study, PFGE analysis was able to distinguish all FQ-S 
and most (17/19, 89%) FQ-R E. coli isolates. Geno- 
typing by PFGE is a powerful tool for studying the 
genetic diversity of E. coli strains and, as in the Ulm 
experience, a similar percentage of FQ-R strains were 
typable (13/16, 81%) [14]. 
RAPD analysis typed two FQ-R isolates that were 
untypable by PFGE, and so was a more sensitive 
technique. Ths could be explained by the fact that, 
although degraded, DNA from these two isolates was 
still available as a template for the primers used in 
RAPD analysis. The results obtained with RAPD using 
different primers yielded different results (four pairs of 
isolates found to be indistinguishable, but seven pairs or 
triads identified as different with the two primers). 
Many factors can affect the reproducibility of RAPD 
analysis, including M$+ concentration [30], batch- 
to-batch variation in primer synthesis [31], ratio of 
DNA template concentration to primer concentration, 
model of thermocycler used 1201, and the supplier and 
concentration of Tuq DNA polymerase [32]. Further- 
more, RAPD is a combination of artifactual variations 
due to the low annealing temperature and true poly- 
morphism [20]. In our experience, RAPD analysis was 
less discriminatory than PFGE for typing both FQ-R 
and FQ-S E. coli isolates. RAPD analysis was unable to 
distinguish between isolates found to be different by 
PFGE. In a previous report, some FQ-R isolates with 
identical RAPD genotypes had different PFGE 
genotypes [ 141. 
A possible explanation for the different discrimina- 
tory power of the two genotyping methods may be that 
PFGE examines about 80% of the genomic DNA, 
while RAPD is able to analyze only 0.1-0.2% of DNA, 
as calculated by the ratio between the sum of the sizes 
of all bands generated by NbuI and the size of the E. coli 
chromosome for PFGE, and the sum of sizes of bands 
generated by RAPD and the size of the E. coli 
chromosome (G. Cardinali, personal communication). 
As observed in this study, the discriminatory index 
(0) of Hunter and Gaston [29] is unable to discriminate 
between genotyping methods that group few strains in 
many types, such as the new genotyping methods. This 
characteristic reduces the capability of this index to 
evaluate the best method for typing a given species. 
However, with the limited number of isolates examined 
in this study, RAPD analysis had a more effective 
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typability, but was less discriminative than PFGE for 
characterizing bacteremic E.  coli isolates. 
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